Prevalence of germline mutations in cancer susceptibility genes in Chinese patients with renal cell carcinoma

• Published in: Translational andrology and urology 2023-02, Vol.12 (2), p.308-319
• Main Authors: Feng, Huayi, Cao, Shouqing, Ouyang, Qing, Li, Huaikang, Li, Xiubin, Chen, Ke, Zhang, Xiangyi, Huang, Yan, Zhang, Xu, Ma, Xin
• Format: Article
• Language: English
• Subjects: Original
• ISSN: 2223-4691; 2223-4683; 2223-4691
• DOI: 10.21037/tau-23-32

Germline pathogenic variants are estimated to affect 3-5% of patients with renal cell carcinoma (RCC). The identification of patients with hereditary RCC is important for cancer screening and treatment guidance. Whole-exome sequencing (WES) (n=69) or gene panel sequencing containing 139 genes (n=54) related to germline cancer predisposition was used to analyze germline mutations in 123 patients with RCC admitted to Department of Urology, The Third Medical Center of Chinese PLA General Hospital. Chi-square test (χ ) was used to analyze relationship between clinicopathologic parameters and germline mutations. A total of 13 (10.57%) patients carried pathogenic or likely pathogenic germline mutations in 10 cancer predisposition genes, including , and . A total of 6 of these 10 cancer predisposition genes were associated with maintenance of genomic stability and DNA repair. Patients harboring pathogenic germline mutations tended to have an earlier RCC onset. The prevalence of deleterious mutations was higher in patients with bilateral or multifocal RCC compared to patients without bilateral or multifocal RCC. Patients with non-clear cell RCC (nccRCC) were significantly more likely to have RCC-associated gene mutations. To our knowledge, this is the first report of pathogenic germline mutations in the and genes and heterozygous germline missense mutation in exon 5 of the gene c.563A>T:p.N188I in RCC. Young RCC patients, patients with bilateral or multifocal RCC, or patients with nccRCC are more likely to have pathogenic/potentially pathogenic germline mutations.